AAH: Pharmacies ‘incorrectly charged’ £2k for £45 drug

CPE has urged pharmacies to “check your invoices” after some were wrongly charged almost £2,000 per pack against NHS prescriptions for cholesterol-lowering medication Inclisiran.

CPE told pharmacies to escalate the issue if AAH does not refund them

Community Pharmacy England (CPE) this week (January 27) called on pharmacies to “check your invoices” as it revealed reports that some have been significantly overcharged by a medicines wholesaler for NHS cholesterol-lowering medication.

It advised pharmacies to ensure they have been charged the correct price by AAH UK for Inclisiran (Leqvio) after some were “incorrectly charged the full NHS list price of £1987.36 per pack instead of the nominal price of £45” against NHS prescriptions.

The issue affects the Inclisiran (Leqvio) 284mg/1.5ml solution for injection pre-filled syringe available to order from AAH UK “as agreed within the commercial agreement between Novartis Pharmaceuticals UK Ltd and NHS England (NHSE)”, it said.

Read more: Medicine wholesaler giant AAH Pharmaceuticals up for sale, say reports

CPE added that pharmacies “should not expect to incur any additional charges or fees from AAH UK” for NHS orders and that they should contact the wholesaler directly to “request a repayment of any additional costs” if they have been overcharged.

If still unresolved, the negotiator advised escalating any issues to Novartis Pharmaceuticals UK and then to CPE itself “should no resolution be identified by the suppliers within five working days of receipt”.

Rectified quickly

CPE told C+D that between January and October 2024, approximately 10,000 items of Inclisiran were dispensed as both a branded and generic product.

It said that the pricing discrepancy largely stems from a difference between pricing for NHS and private prescriptions, both of which a single pharmacy could be handling and that all identified cases had been rectified quickly.

CPE added that AAH may not always be aware if an order for a product is being made to supply against an NHS or a private prescription.

Read more: What happens in the warehouse

And it said that “for dispensing against private prescriptions, stock must be obtained directly from Novartis Pharmaceuticals UK…charged at the current full NHS list price of £1987.36 per pack”.

C+D approached AAH UK for comment.

It comes amid reports in September that AAH was primed to be sold by its German private equity owner Aurelius who hoped to sell the wholesaler for “around” £900 million.

Sign in or register for free

Latest from Business

Paydens rolls out free ‘drinking check’ across 128 pharmacies

 
• By 
 • comment

Alcohol harm charity Drinkaware has partnered with Paydens Pharmacy to rollout a free “drinking check” in 128 of its stores in southeast England to “assess” the drinking habits of customers.

‘Don’t sign up!’: LPC chief advises against new smoking service over fees and safety concerns

 
• By 
 • comment

A new SLA sent out for a local varenicline smoking cessation service means pharmacists who take up the service will be operating at a loss, and result in “clinical risk” if they take up the service.

Salary Survey: What does community pharmacy think about Hub and Spoke?

  • comment

If you wanted to describe the potential effect of Hub & Spoke as transformational, you’d be right. What the ultimate effect of that transformation might be remains up for debate.

More from News

Tesco relaunches free blood pressure checks for shoppers

 
• By 
 • comment

Tesco has partnered with the British Heart Foundation to launch a free NHS blood pressure check for shoppers to “help detect cases of undiagnosed high blood pressure and prevent cardiovascular events like heart attacks and strokes”.

GPhC to spend £300k on legal fees as FtP performance slides to red

 
• By 
 • comment

The pharmacy regulator has set aside an extra £0.3m for external legal advice as its fitness-to-practice performance falls from amber to red.